Strovite One Caplets
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Strovite One Caplets
- Generic name
- VITAMIN A, CALCIUM PANTOTHENATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL SUCCINATE, D-, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, BIOTIN, CYANOCOBALAMIN, SELENIUM, MAGNESIUM OXIDE, ZINC OXIDE, CUPRIC SULFATE, MANGANESE, CHROMIUM, .ALPHA.-LIPOIC ACID, AND LUTEIN
- Manufacturer
- Exeltis USA, Inc.
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- b9b71fa4-89c7-4f5b-8174-950649434ba5
- SPL ID
- 30c8e7e7-7cba-c12f-e063-6394a90a41e9
- Version
- 5
- Effective date
- 2025-03-20
- Source export date
- 2026-09-28
- Source partition
- 14
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0014-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/db99fd80353afecef4949b48edcaa018be72b966b2360184251eb14df43743f9/drug-label-0014-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:40:31
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Strovite One Caplets | openfda.brand_name | |
| generic name | VITAMIN A, CALCIUM PANTOTHENATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL SUCCINATE, D-, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, BIOTIN, CYANOCOBALAMIN, SELENIUM, MAGNESIUM OXIDE, ZINC OXIDE, CUPRIC SULFATE, MANGANESE, CHROMIUM, .ALPHA.-LIPOIC ACID, AND LUTEIN | openfda.generic_name | |
| manufacturer name | Exeltis USA, Inc. | openfda.manufacturer_name | |
| ndc | package | 0642-0207-90 | openfda.package_ndc |
| ndc | package | 0642-0207-03 | openfda.package_ndc |
| ndc | product | 0642-0207 | openfda.product_ndc |
| ndc11 | package | 00642020703 | derived:openfda.package_ndc |
| ndc11 | package | 00642020790 | derived:openfda.package_ndc |
| spl id | 30c8e7e7-7cba-c12f-e063-6394a90a41e9 | id | |
| spl set id | b9b71fa4-89c7-4f5b-8174-950649434ba5 | set_id | |
| unii | LRX7AJ16DT | openfda.unii | |
| unii | 25X51I8RD4 | openfda.unii | |
| unii | 42Z2K6ZL8P | openfda.unii | |
| unii | TLM2976OFR | openfda.unii | |
| unii | 935E97BOY8 | openfda.unii | |
| unii | 73Y7P0K73Y | openfda.unii | |
| unii | PQ6CK8PD0R | openfda.unii | |
| unii | SOI2LOH54Z | openfda.unii | |
| unii | 81G40H8B0T | openfda.unii | |
| unii | 3A3U0GI71G | openfda.unii | |
| unii | LU4B53JYVE | openfda.unii | |
| unii | 568ET80C3D | openfda.unii | |
| unii | 6SO6U10H04 | openfda.unii | |
| unii | P6YC3EG204 | openfda.unii | |
| unii | X72A60C9MT | openfda.unii | |
| unii | 68Y4CF58BV | openfda.unii | |
| unii | 0R0008Q3JB | openfda.unii | |
| unii | 1C6V77QF41 | openfda.unii | |
| unii | X66NSO3N35 | openfda.unii | |
| unii | H6241UJ22B | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNING/PRECAUTIONS Vitamin D supplementation should be used with caution in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones. High doses of vitamin D can lead to elevated levels of calcium that reside in the blood and soft tissues. Bone pain, high blood pressure, formation of kidney stones, renal failure, and increased risk of heart disease can occur. Folic acid, especially in doses above 0.1 mg daily, may obscure pernicious anemia, in that hematologic remission may occur while neurological manifestations remain progressive. The use of folic acid doses above 1 mg daily may precipitate or exacerbate the neurological damage of vitamin B12 deficiency. Avoid overdosage. Keep out of the reach of children.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS Adverse reactions have been reported with specific vitamins and minerals, but generally at levels substantially higher than those in STROVITE ® ONE.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.